U-Chart Analysis:K Pharma,Inc.:4896

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index K Pharma,Inc. 4896 Medicals 東証グロース December 1, 2000 2023.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

K Pharma,Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

K Pharma,Inc. Balance Sheet 2023年12月期 K Pharma,Inc. Balance Sheet 2022年12月期 K Pharma,Inc. Balance Sheet 2021年12月期 K Pharma,Inc. Balance Sheet 2020年12月期 K Pharma,Inc. Balance Sheet 年0月期

K Pharma,Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

K Pharma,Inc. Profit and Loss Account 2023年12月期 K Pharma,Inc. Profit and Loss Account 2022年12月期 K Pharma,Inc. Profit and Loss Account 2021年12月期 K Pharma,Inc. Profit and Loss Account 2020年12月期 K Pharma,Inc. Profit and Loss Account 年0月期

K Pharma,Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

K Pharma,Inc. Cash Flow Statement 2023年12月期 K Pharma,Inc. Cash Flow Statement 2022年12月期 K Pharma,Inc. Cash Flow Statement 2021年12月期 K Pharma,Inc. Cash Flow Statement 2020年12月期 K Pharma,Inc. Cash Flow Statement 年0月期

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

K Pharma,Inc.

Company where related level is highHelp

Fuji Pharma Co.,Ltd.
SSP CO.,LTD.
HISAMITSU PHARMACEUTICAL CO.,INC.
GNI Group Ltd.
Immuno-Biological Laboratories Co., Ltd.
Nxera Pharma Co., Ltd.
BrightPath Biotherapeutics Co., Ltd.
Sanko Junyaku Co.,Ltd.
Mochida Pharmaceutical Co.,Ltd.
Modalis Therapeutics Corporation